Zymeworks ZYME Payments to Acquire Intangible Assets
Payments to Acquire Intangible Assets at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.
The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zymeworks's payments to acquire intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zymeworks's payments to acquire intangible assets?
- Zymeworks (ZYME) reported payments to acquire intangible assets of $0 in Q1 2026.
- How has Zymeworks's payments to acquire intangible assets changed year-over-year?
- Zymeworks's payments to acquire intangible assets decreased by 100.0% year-over-year, from $322K to $0.
- What is the long-term trend for Zymeworks's payments to acquire intangible assets?
- Over 3 years (2022 to 2025), Zymeworks's payments to acquire intangible assets has grown at a -44.9% compound annual growth rate (CAGR), from $4.98M to $831K.
- What does payments to acquire intangible assets mean?
- Cash outflows related to the purchase or development of non-physical assets, such as patents, intellectual property, or software licenses. For biopharmaceutical companies, this often represents investment in the core technology or drug pipeline assets.